Daily Archives: July 24, 2022

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Unilever PLC Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – UL

NEW YORK, July 24, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Unilever PLC (NYSE: UL) between September 2, 2020 and July 21, 2021, both dates inclusive (the “Class Period”),

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Digital Turbine, Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action – APPS

NEW YORK, July 23, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Digital Turbine, Inc. (NASDAQ: APPS) between August 9, 2021 and May 17, 2022, both dates inclusive (the “Class

ROSEN, A LEADING LAW FIRM, Encourages Teladoc Health, Inc. Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action – TDOC

NEW YORK, July 23, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Teladoc Health, Inc. (NYSE: TDOC) between October 28, 2021 and April 27, 2022, both dates inclusive (the “Class

ROSEN, A LEADING LAW FIRM, Encourages Outset Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OM

NEW YORK, July 23, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Outset Medical, Inc. (NASDAQ: OM) between September 15, 2020 and June 13, 2022, both dates inclusive (the “Class

APYX DEADLINE NOTICE: NATIONALLY RANKED ROSEN LAW FIRM Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important August 5 Deadline in Securities Class Action – APYX

NEW YORK, July 23, 2022 (GLOBE NEWSWIRE) — WHY:  Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Apyx Medical Corporation (NASDAQ: APYX) between May 12, 2021 and March 11, 2022, both dates inclusive (the